EUVIMEDEUVIMED entdecken
Crossref

The Efficacy and Safety of an Intra-articular Dual-Acting Antibacterial Agent (TNP-2092) for Implant Infection–Associated Methicillin-Resistant Staphylococcus aureus

Tianyu Dai, Chi Ma, Fan Zhang, Hui Wang iD, Zhenkun Ma, Huan Wang, Yinxian Wen, Liaobin Chen

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Tianyu Dai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus, Prosthesis-Related Infections, Staphylococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research and Development, Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Owing to the presence of microbial biofilm on the implant, the eradication of biofilm-associated infections poses a challenge for antibiotic therapies. The study aimed to investigate the efficacy and safety of the novel antibiotic agent TNP-2092 in the context of implant infections. In vivo, rats with periprosthetic joint infection (PJI) treated with antibiotics showed an increase in body weight and decrease in swelling, temperature, and width of knee, compared with the control group. Meanwhile, inflammatory markers in synovium and serum were decreased in the TNP-2092 group, consistent with the pathological results. Moreover, TNP-2092 was effective in eliminating bacteria and disruption biofilm formation, and further alleviated the abnormal bone absorption and reactive bone changes around the prosthesis. In conclusion, intra-articular injection of TNP-2092 is safe and effective in treating knee PJI in a rat model. The study provides a foundation for the future utilization of TNP-2092 in the management of implant-related infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusProsthesis-Related InfectionsStaphylococcal InfectionsBiofilmsAnimalsRatsMaleInjections, Intra-ArticularRats, Sprague-DawleyDisease Models, Animal

Stichwörter der Autor:innen

TNP-2092implant infectionmethicillin-resistant Staphylococcus aureusmicrobial biofilm

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Joint Surgery and Sports Medicine, Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan.
  • Department of Orthopedics, The First Affiliated Hospital of Jishou University, Jishou.
  • Department of Pharmacology, Wuhan University School of Basic Medical Sciences, Wuhan.
  • Department of Pharmacology & Toxicology, TenNor Therapeutics, Suzhou.
  • Joint Disease Research Center of Wuhan University, Wuhan University, Wuhan, China.

ORCID-Profile: Hui Wang

Förderung

  • National Natural Science Foundation of China
  • Research and Development
  • Project
  • Wuhan University
  • TenNor Therapeutics Suzhou Ltd

Zitieren

APA

Dai, T., Ma, C., Zhang, F., Wang, H., Ma, Z., Wang, H., Wen, Y., & Chen, L. (2024). The Efficacy and Safety of an Intra-articular Dual-Acting Antibacterial Agent (TNP-2092) for Implant Infection–Associated Methicillin-Resistant Staphylococcus aureus. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad588

Vancouver

Dai T, Ma C, Zhang F, Wang H, Ma Z, Wang H, et al. The Efficacy and Safety of an Intra-articular Dual-Acting Antibacterial Agent (TNP-2092) for Implant Infection–Associated Methicillin-Resistant Staphylococcus aureus. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad588

BibTeX
@article{Dai2024,
  author = {Dai, Tianyu and Ma, Chi and Zhang, Fan and Wang, Hui and Ma, Zhenkun and Wang, Huan and Wen, Yinxian and Chen, Liaobin},
  title = {The Efficacy and Safety of an Intra-articular Dual-Acting Antibacterial Agent (TNP-2092) for Implant Infection–Associated Methicillin-Resistant Staphylococcus aureus},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad588}
}
Kostenlos starten →